Royal Bank of Canada’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.4M Buy
1,538,641
+1,528,625
+15,262% +$12.4M ﹤0.01% 1694
2025
Q1
$84K Sell
10,016
-5,706
-36% -$47.9K ﹤0.01% 4967
2024
Q4
$124K Sell
15,722
-22,117
-58% -$174K ﹤0.01% 4743
2024
Q3
$314K Buy
37,839
+4,438
+13% +$36.8K ﹤0.01% 4044
2024
Q2
$212K Sell
33,401
-70,889
-68% -$450K ﹤0.01% 4341
2024
Q1
$632K Buy
104,290
+32,445
+45% +$197K ﹤0.01% 3410
2023
Q4
$436K Buy
71,845
+14,517
+25% +$88.1K ﹤0.01% 3881
2023
Q3
$242K Buy
57,328
+7,749
+16% +$32.7K ﹤0.01% 4154
2023
Q2
$153K Buy
49,579
+5,993
+14% +$18.5K ﹤0.01% 4549
2023
Q1
$60K Sell
43,586
-11,574
-21% -$15.9K ﹤0.01% 5139
2022
Q4
$109K Buy
55,160
+16,885
+44% +$33.4K ﹤0.01% 4917
2022
Q3
$77K Buy
38,275
+835
+2% +$1.68K ﹤0.01% 4998
2022
Q2
$119K Sell
37,440
-5,548
-13% -$17.6K ﹤0.01% 4759
2022
Q1
$180K Sell
42,988
-13,093
-23% -$54.8K ﹤0.01% 4702
2021
Q4
$269K Buy
56,081
+3,082
+6% +$14.8K ﹤0.01% 4532
2021
Q3
$283K Buy
52,999
+3,995
+8% +$21.3K ﹤0.01% 4347
2021
Q2
$251K Sell
49,004
-13,504
-22% -$69.2K ﹤0.01% 4410
2021
Q1
$421K Sell
62,508
-1,548
-2% -$10.4K ﹤0.01% 3881
2020
Q4
$292K Buy
64,056
+351
+0.6% +$1.6K ﹤0.01% 4051
2020
Q3
$247K Buy
63,705
+16,930
+36% +$65.6K ﹤0.01% 3931
2020
Q2
$222K Sell
46,775
-8,360
-15% -$39.7K ﹤0.01% 3934
2020
Q1
$191K Sell
55,135
-86,286
-61% -$299K ﹤0.01% 3891
2019
Q4
$682K Buy
141,421
+66,477
+89% +$321K ﹤0.01% 3213
2019
Q3
$218K Sell
74,944
-52,866
-41% -$154K ﹤0.01% 3845
2019
Q2
$916K Buy
127,810
+3,704
+3% +$26.5K ﹤0.01% 2891
2019
Q1
$1.76M Buy
124,106
+67,353
+119% +$955K ﹤0.01% 2365
2018
Q4
$768K Sell
56,753
-20,190
-26% -$273K ﹤0.01% 2836
2018
Q3
$1.71M Buy
76,943
+9,111
+13% +$202K ﹤0.01% 2473
2018
Q2
$1.11M Buy
+67,832
New +$1.11M ﹤0.01% 2652